161
Participants
Start Date
August 14, 2012
Primary Completion Date
March 31, 2016
Study Completion Date
June 11, 2018
Immunosuppression withdrawal
Participants will undergo gradual ISW in no less than 36 weeks and no more than 52 weeks with frequent monitoring of liver tests. All participants will be followed for 48 months ensuring a minimum of 36 months of follow-up after successful ISW.
New York Presbyterian Morgan Stanley Children's Hospital - Columbia University Medical Center, New York
Children's Hospital of Pittsburgh, Pittsburgh
Children's Hospital of Philadelphia, Philadelphia
Emory University and Children's Hospital of Atlanta, Atlanta
Cincinnati Children's Hospital, Cincinnati
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
St. Louis Children's Hospital - Washington University, St Louis
Texas Children's Hospital, Houston
Children's Hospital of Colorado, Aurora
University of Michigan C. S. Mott Children's Hospital, Ann Arbor
University of California, San Francisco
The Hospital for Sick Children, Toronto
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Immune Tolerance Network (ITN)
NETWORK
National Institute of Allergy and Infectious Diseases (NIAID)
NIH